Drugs / Pegylated Recombinant Human G-CSF
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT02725606 Comparator | Mar 2016 → Sep 2017 | neutropenia | Jiangsu T-Mab Biopharma Co.,Ltd | Unknown | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Pegylated Recombinant Human G-CSF | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02725606 ↗ |